Van Buuren v Chief Constable of Cambridgeshire Constabulary - Police Conduct Appeal

The Court of Appeal (Civil Division) dismissed an appeal (CA-2025-000399 and CA-2025-000458) brought by Gijsbert Lucas Van Buuren against decisions of the Chief Constables of Cambridgeshire, Hertfordshire, and Bedfordshire Constabularies, and the Independent Office for Police Conduct. The appeal originated from Mr Justice Sweeting's judgment in the King's Bench Division ([2025] EWHC 195 KB).

Julia Mazur v Charles Russell Speechlys LLP - Legal Services Regulation

The Court of Appeal (Civil Division) issued judgment [2026] EWCA Civ 369 in Julia Mazur and Another v Charles Russell Speechlys LLP and Others, with multiple legal regulators (SRA, Law Society, CILEX, LSB) as parties or interveners. The three-judge panel presided by the Master of the Rolls addressed appeals from Mr Justice Sheldon. The judgment establishes precedent on legal services regulation affecting solicitors, CILEX members, and law firms in England and Wales.

R v Norbert Maiksner - Sentencing

Norbert Maiksner was sentenced at Portsmouth Crown Court by Mr Justice Murray on 30 March 2026. This is a sentencing judgment following a criminal conviction. The specific offences and sentence imposed are detailed in the full sentencing remarks PDF.

Yuriy Dmitriyev v. Russia - Pre-trial Detention and Fair Hearing

The European Court of Human Rights found Russia violated Article 5 § 3 (reasonableness of pre-trial detention) and Article 6 (right to fair hearing) in the case of Yuriy Dmitriyev. The Court determined domestic courts failed to provide relevant and sufficient reasons justifying the first period of pre-trial detention, and the appellate court failed to demonstrate sufficient grounds for overriding the applicant's choice of counsel. The Article 18 complaint regarding ulterior purpose was dismissed as inadmissible.

Makki v. Denmark - Article 3 Violation (Inhuman and Degrading Treatment)

The European Court of Human Rights found Denmark violated Article 3 (prohibition of torture) by subjecting Mr. Makki, a paranoid schizophrenia patient, to 11 days and 11 hours of physical restraint in a psychiatric hospital. The Court ruled the prolonged restraint pending transfer to a high security facility was inhuman and degrading treatment and not strictly necessary. Denmark is bound by this judgment requiring compliance with ECHR standards on psychiatric restraint.

X v. Georgia - Art 3 and Art 8 Sexual Abuse Investigation

The European Court of Human Rights found Georgia violated Articles 3 and 8 of the European Convention on Human Rights by failing to conduct an effective criminal investigation into allegations of child sexual abuse. The Court identified systemic investigative delays, state inaction, and secondary victimisation of the applicant (a minor) throughout proceedings.

Murex Petroleum Crude Oil Spill Notification - Divide County

NDDEQ issued a news release notifying the public of a crude oil spill by Murex Petroleum Corporation in Divide County, North Dakota. The tank failure on March 26 released approximately 238 barrels (9,996 gallons) of crude oil, with 133 barrels impacting adjacent agricultural land. NDDEQ personnel are inspecting the site and monitoring remediation activities.

Attorney Melegia Lee Daniels Jr Interim Suspension

The Supreme Court of South Carolina issued an interim suspension order against attorney Melegia Lee Daniels Jr pursuant to Rule 17(b), RLDE, Rule 413, SCACR, effective immediately on March 30, 2026. The court appointed John Earle Tyler, Esquire as receiver to assume responsibility for Daniels's client files, trust accounts, escrow accounts, operating accounts, and any other law office accounts. This order prevents Daniels from practicing law in any court in South Carolina or the United States until further order of the Court.

Confirmation of Effective Date for Backfilling and Grading Rule

OSMRE confirmed the March 30, 2026 effective date for a direct final rule rescinding 30 CFR 816.101, which contained suspended time and distance performance standards for backfilling and grading at surface mining operations. The suspended regulation had been inoperable since 1992. Two timely comments were reviewed and determined not to be significant adverse comments warranting withdrawal or modification of the rule.

Shipbuilding Industrial Base Demographics Survey

The Naval Sea Systems Command announced a proposed information collection under the Paperwork Reduction Act for the Shipbuilding Industrial Base Demographics Survey, with comments due June 1, 2026. The survey targets 1,263 private companies and organizations in the shipbuilding supply chain to analyze demographics, training requirements, and occupational experience. This biennial collection supports Section 1026 of the FY2021 NDAA mandate for Congress to receive regular reports on the shipbuilding industrial base workforce.

Senate Gift Shop FY 2024 Receipts and Disbursements Audit

The U.S. Government Accountability Office (GAO) issued an agreed-upon procedures audit of the Senate Gift Shop Revolving Fund's fiscal year 2024 receipts and disbursements, as requested by the Senate Committee on Rules and Administration. The audit reviewed daily receipts, weekly deposits, monthly reconciliations, purchasing, and invoice payment processes. GAO makes no overall conclusions, with the Secretary of the Senate providing no comments on the report.

Morellato fined €25.9M for anti-competitive jeweller discounts

The Italian Competition Authority (AGCM) fined Morellato S.p.A. €25,895,043 for implementing anti-competitive vertical agreements in its selective distribution system for mid-range jewellery and watches. The violations, spanning July 2018 to December 2025, included imposing maximum resale discounts on online sales and prohibiting distributors from selling on third-party marketplaces like Amazon and eBay.

Ombudsman Service Sets Plans for Service Delivery Reforms for Year Ahead

The Financial Ombudsman Service (FOS) has published its 2026/27 Plans and Budget, outlining its most significant operational transformation in 25 years. Working with the FCA and government, the FOS will focus on delivering quicker, clearer, and easier service through new digital tools and process improvements. An FCA consultation (CP26-9) has been issued to update FOS processes and improve transparency for customers.

Young's Market v. WA Dept of Revenue - Tax Appeal

The Washington Court of Appeals Division I filed an opinion in Young's Market Company of WA, LLC v. State of Washington Department of Revenue (Docket No. 87614-7), affirming the lower court's judgment dated June 13, 2024. The three-judge panel, authored by Judge Lori Smith with concurrences from Judges Janet Chung and Leonard Feldman, resolved the tax dispute between the alcoholic beverage distributor and the state tax authority.

State v. Kane - Criminal Appeal

The Washington Court of Appeals Division I filed an opinion affirming the conviction of Sean Alan Kane (Docket No. 86684-2). The case was decided by a three-judge panel authored by Judge Tam Bui, with Judges Coburn and Diaz concurring. The judgment under review was originally filed on May 10, 2024, by King County Superior Court Judge Annette Messitt.

In the Matter of the Detention of I.H.

Washington Court of Appeals Division I filed an opinion in the civil detention matter of I.H. (Docket 87109-9), affirming the King County Superior Court's judgment from August 12, 2024. The three-judge panel (Bui, Mann, Chung) issued the opinion on March 30, 2026, reviewing the involuntary detention order under applicable Washington civil commitment standards.

25SA146 - Nature of Case Undetermined

Colorado Supreme Court issued opinion 25SA146. The page also contains administrative announcements including early court closures at Logan Combined Court (April 3), 13th Judicial District (April 16), and Phillips County Combined Court (March 31). Denver Courts and Police Department issued a public warning regarding a new toll and summons scam.

Clinical investigations for medical devices

MHRA published guidance explaining requirements for clinical investigations of medical devices in Great Britain under the UK MDR 2002. Manufacturers must notify MHRA of planned investigations involving non-UKCA or non-CE marked devices on human participants unless an exemption applies. The guidance clarifies different regulatory pathways for Great Britain versus Northern Ireland.

Clinical Investigations in Northern Ireland for Medical Devices

MHRA published guidance clarifying clinical investigation requirements for medical devices in Northern Ireland under the EU Medical Device Regulation (EU MDR) 2017/745 and In Vitro Diagnostic Medical Device Regulation (EU IVDR) 2017/746. Manufacturers must notify MHRA when using non-UKCA or non-CE marked devices on human participants. The guidance establishes that a single EU MDR application covers sites in both Northern Ireland and Great Britain.

Monthly Drug and Medical Device Safety Roundup

MHRA published its monthly safety roundup for March 2026, consolidating alerts on medicines and medical devices. The roundup includes multiple drug and device batch recalls affecting various therapeutic areas. Healthcare providers and patients should review the specific alerts to identify affected products in their supply chain or treatment.

Exempt Collective Trust Funds from FINRA Rules 5130 and 5131(b)

FINRA filed SR-FINRA-2026-007 with the SEC proposing to exempt specified collective trust funds (CTFs) from FINRA Rule 5130 (restrictions on IPO purchases) and Rule 5131(b) (spinning restrictions). The exemption would allow qualifying CTFs to participate in new equity offerings currently restricted under these rules.

Wearable device for differential measurement on pulse rate and blood flow

USPTO granted patent US12588820B2 to OMNI MEDSCI, INC. (inventor Mohammed N. Islam) on March 31, 2026. The patent covers a wearable device with biosensors, LED light sources, and AI-based analysis for measuring pulse rate and blood flow through differential optical measurement.

OCT catheter with low refractive index optical material

The USPTO granted Patent US12588819B2 to Elumn8 Medical, Inc. for an OCT catheter with low refractive index optical filler material designed to reduce imaging artifacts during medical procedures. The patent covers 26 claims relating to catheter devices combining imaging and intervention capabilities with a tapered distal end serving as a crossing tool for occluded vessels. Inventors include John B. Simpson, Kin Foong Chan, Wendy Lam, Sergio Salinas, and Evangeline Lumabas.

Second Circuit appeal, multiple plaintiffs vs PLO, decision 30th Mar

Second Circuit appeal, multiple plaintiffs vs PLO, decision 30th Mar

THE702FIRM Trademark Published for Opposition

USPTO published trademark application TM99525826 for THE702FIRM on March 30, 2026, covering legal services including legal advisory, document preparation, and mediation services. Third parties have a 30-day window from publication to file an opposition if they believe registration would cause harm.

THE702FIRM Injury Attorneys Trademark Published for Opposition

USPTO published trademark application TM99525786 for THE702FIRM INJURY ATTORNEYS for opposition. The trademark covers legal services including legal notice service, legal advisory services, document preparation, and mediation. Third parties have a statutory window to file opposition before registration can proceed.

Blue Iron Investigations and Security - Trademark Application

The USPTO published trademark application TM99507863 for 'BLUE IRON INVESTIGATIONS AND SECURITY' covering security guard services (Class 45) on March 30, 2026. The application was originally filed on November 20, 2025. This publication initiates the opposition period during which third parties may challenge the registration.

Heritage Title Company Trademark Application

The USPTO published trademark application TM99512901 for HERITAGE TITLE COMPANY, an Intent to Use application covering real estate title searching, closing services, title insurance underwriting, escrow services, and insurance consulting. The application was filed November 24, 2025. This is an informational trademark publication with no compliance obligations or deadlines.

IO Biotech Inc Chapter 7 Bankruptcy Filing

SEC Form 8-K filed by IO Biotech, Inc. disclosing Chapter 7 bankruptcy filing on March 31, 2026. The company ceased operations and filed a voluntary petition in the U.S. Bankruptcy Court for the District of Delaware. A Chapter 7 trustee has been appointed to liquidate assets and pay claims. The filing triggers an event of default on a €22.5 million finance contract with the European Investment Bank.

IBM patent for entity-wide database asset index generation

USPTO granted patent US12591704B2 to International Business Machines Corporation for entity-wide database asset index generation methods. The patent covers technology for identifying database instances across multiple security monitoring systems and linking same instances observed by different systems to detect database security threats. The patent includes 20 claims and names inventors Oded Sofer, Aviv Ron, and Shachaf Katz.

Testing functionality of and generating on-chain programs

The USPTO granted Citibank Patent US12591501B1 on March 31, 2026, covering systems and methods for testing and generating on-chain blockchain programs. The patent includes 18 claims and describes functionality for generating on-chain program code by determining models, retrieving functions, and determining blockchain operations with parameters. The system also tests on-chain programs by installing them on a test blockchain and generating operations for cryptography-based storage applications.

Systems and Methods for Dynamically Anonymizing Geospatial Data for Secure Analytics

USPTO granted Patent US12591709B2 to Anonos Innovations LLC on March 31, 2026. The patent covers systems and methods for dynamically anonymizing geospatial data, enabling data subjects to remain anonymous for desired periods and to desired degrees while facilitating privacy-preserving analytics, AI, and machine learning applications.

Cyber Risk Monte Carlo Simulation Patent for Financial Loss Characterization

USPTO granted patent US12591753B2 to Zscaler, Inc. on March 31, 2026. The patent covers systems and methods for analyzing cybersecurity monitoring data to determine financial risk using Monte Carlo simulation to characterize potential losses from cyber events. The simulation inputs are based on the organization's industry, size, and current cyber risk posture.

Anti-C-MPL antibody and use thereof

USPTO granted patent US12590161B2 to Daegu Gyeongbuk Institute of Science and Technology for an anti-C-MPL antibody (2R13) that increases platelet production through megakaryocyte maturation. The antibody offers longer half-life than conventional therapeutic agents with lower self-antibody production and reduced immunogenicity. The patent covers therapeutic applications for chronic or complication-induced immune thrombocytopenia.

EGFR Bispecific Antibody Patent Grant - Amunix Pharmaceuticals

The USPTO granted patent US12590159B2 to Amunix Pharmaceuticals covering compositions targeting EGFR, including protease-activatable bispecific fusion proteins such as T cell engagers. The patent includes 8 claims for antibody binding domains targeting CD3 and EGFR, cleavable linker sequences, and methods of treatment for conditions such as cancer.

PD-L1 Binding Molecules and Uses Thereof

USPTO granted Patent US12590155B2 to Beijing Mabworks Biotech Co., Ltd. for molecules (single-domain antibodies and heavy chain only antibodies) that specifically bind human PD-L1 for use in treating tumors and related diseases. The patent contains 17 claims and covers the分子的 therapeutic applications in cancer treatment.

CD3-specific binding molecules

The USPTO granted Immunocore Limited Patent US12590152B2 covering CD3-specific binding molecules, specifically antibodies and fragments with improved properties. The patent contains 19 claims and names 8 inventors including Martina Canestraro and Stephen Harper. This is a routine patent grant establishing intellectual property rights without regulatory compliance obligations.

Bi-specific Chimeric Antigen Receptor for TGF-beta Binding

USPTO granted patent US12590145B2 to The Regents of the University of California on March 31, 2026, covering a bi-specific chimeric antigen receptor (CAR) that specifically binds TGF-beta. The CAR technology neutralizes TGF-beta while simultaneously triggering T-cell activation, converting an immunosuppressive signal into an activating stimulus. The patent contains 10 claims with application number 17323568, filed May 18, 2021.

Antibodies binding to citrullinated histone 2A and/or 4

USPTO granted Patent No. 12,590,143 B2 to Citryll B.V. for antibodies binding to citrullinated histone 2A and/or 4, covering therapeutic applications for Neutrophil Extracellular Trap (NET)-associated pathologies. The patent includes 13 claims and covers both the antibodies and binding fragments for use in treatment.

Anti-Henipavirus Monoclonal Antibodies with Broad Spectrum Neutralization

The USPTO granted Patent US12590141B2 to the Academy of Military Medical Science covering monoclonal antibodies targeting Henipavirus glycoprotein G. The patent claims antibodies combining macaque variable regions with human constant regions, demonstrating broad neutralization activity against Nipah and Hendra viruses. The patent includes 9 claims and covers encoding nucleic acids for therapeutic applications.

GLP-1 agonist polypeptide compound and salt thereof, synthesis method therefor and use thereof

USPTO granted patent US12590134B2 to SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. for a GLP-1 agonist polypeptide compound (SEQ ID NO: 1) used in diabetes and obesity treatment. The patent includes 2 claims covering the compound, salt forms, synthesis method, and therapeutic applications. Filing date was August 17, 2022, under application number 17820251.

GLP-1/GIP Dual Agonist Patent for Diabetes Treatment

USPTO granted patent US12589158B2 to Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. for long-acting GLP-1/GIP dual agonist compounds for treating Type II diabetes mellitus. The patent covers compounds with dual agonistic effects on glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors.

Benzimidazole and Benzimidazolone Based PROTAC Compounds for LRRK2 Degradation

The USPTO granted Arvinas Operations, Inc. patent US12589156B2 covering benzimidazole and benzimidazolone PROTAC compounds designed to recruit LRRK2 protein to E3 ubiquitin ligase for targeted degradation. The patent contains 12 claims and was filed on March 24, 2025.

Use of D9-methadone for postoperative pain relief

USPTO granted Patent US12590054B2 to the Board of Regents, The University of Texas System, covering the use of d9-methadone as an alternative formulation for methadone with improved pharmacokinetic properties for postoperative pain relief. The patent includes 15 claims and covers compositions and methods for managing pain following injury, disease, or surgery.

Crystalline acetylcholinesterase inhibitor forms A, B, C for neurodegenerative diseases

USPTO granted Patent US12590061B2 to Shanghai Institute of Materia Medica, Chinese Academy of Sciences covering crystalline forms A, B, and C of an acetylcholinesterase inhibitor compound (2-((1-(2-fluorobenzyl)-4-fluoropiperidin-4-yl)methylene)-5,6-dimethoxy-2,3-dihydro-1-indanone). The patent, filed November 24, 2020 as Application No. 17780449 with 10 claims, protects the stable, low-hygroscopicity crystalline forms used for preventing and treating neurodegenerative diseases.

Gilead PD-1/PD-L1 inhibitors, cancer treatment compounds

USPTO granted Gilead Sciences, Inc. Patent US12590062B2 for PD-1/PD-L1 inhibitor compounds for cancer treatment. The patent covers compounds according to formula (I), methods of using said compounds singly or in combination with additional agents, and compositions for treating cancer. Application No. 17098171 was filed November 13, 2020, and the patent contains 18 claims.

General Reclamation Requirements - Direct Final Rule Effective Date Confirmation

The Office of Surface Mining Reclamation and Enforcement (OSMRE) is confirming the effective date of March 30, 2026, for a direct final rule that rescinds obsolete language regarding compliance requirements for prior balance replacement funds used in reclamation projects. OSMRE reviewed four timely public comments and determined none constituted significant adverse comments warranting withdrawal or modification of the rule.

PRC Final Rule on Off-the-Record Procedures

The Postal Regulatory Commission published a final rule amending 39 CFR parts 3010 and 3012 to clarify permissible informal, off-the-record procedures at prehearing conferences. The rule specifies that prehearing conferences, technical conferences, settlement conferences, and alternative dispute resolution are permissible provided advance public notice and participation opportunity is given to all parties. These procedures are clarified as not constituting ex parte communications.

Section 74.802 Low Power Auxiliary Stations Co-channel Coordination Information Collection Review

The FCC invites public comment on extending OMB Control No. 3060-1205 for Section 74.802 regarding Low Power Auxiliary Stations Co-channel Coordination with TV Broadcast Stations. The collection affects 217 respondents with an estimated annual burden of 217 hours and total annual cost of $27,125. Comments must be submitted by June 1, 2026.

FCC Expands Broadband Access in 900 MHz Band

The FCC adopted a Report and Order (FCC 26-9) in WT Docket 24-99 making broadband available across all ten megahertz of the 896-901/935-940 MHz band. The final rule creates three licensing options: narrowband licenses, paired three-megahertz (3/3) broadband licenses, and paired five-megahertz (5/5) broadband licenses. Existing 900 MHz licensees may transition to 5/5 broadband licenses while incumbents may maintain narrowband and 3/3 segment uses.